Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
US Army
Harvard Business School
Cantor Fitzgerald
Covington
Dow
Healthtrust
Federal Trade Commission
Boehringer Ingelheim

Generated: October 20, 2017

DrugPatentWatch Database Preview

Bel Mar Company Profile

« Back to Dashboard

What is the competitive landscape for BEL MAR, and what generic and branded alternatives to BEL MAR drugs are available?

BEL MAR has twenty-six approved drugs.



Summary for Applicant: Bel Mar

US Patents:0
Tradenames:18
Ingredients:17
NDAs:26
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar
HYDROCORTISONE ACETATE
hydrocortisone acetate
INJECTABLE;INJECTION083739-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
PREDNISOLONE ACETATE
prednisolone acetate
INJECTABLE;INJECTION083738-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate
INJECTABLE;INJECTION080821-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
PYRIDAMAL 100
chlorpheniramine maleate
INJECTABLE;INJECTION083733-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION080710-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
THIAMINE HYDROCHLORIDE
thiamine hydrochloride
INJECTABLE;INJECTION080718-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
HYDROXOMIN
hydroxocobalamin
INJECTABLE;INJECTION084629-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
TESTOSTERONE PROPIONATE
testosterone propionate
INJECTABLE;INJECTION080743-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
RUBIVITE
cyanocobalamin
INJECTABLE;INJECTION010791-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
RUBIVITE
cyanocobalamin
INJECTABLE;INJECTION010791-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Fuji
Mallinckrodt
Johnson and Johnson
McKinsey
Moodys
Citi
UBS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot